- Commercialisation of MABR exceeds defined Milestones -
Emefcy Second Milestone and Vendor Shareholder Understanding
Melbourne, Dec 5, 2017 AEST (ABN Newswire) - Fluence Corporation Limited (
ASX:FLC) (EMFGF:OTCMKTS) ("Fluence" or the "Company"), a global leader in decentralized water and wastewater treatment solutions, today announced that as previously disclosed under the terms of the Savcor Group Limited (now known as Fluence Corporation Limited) and Emefcy Ltd Share Exchange and Purchase Agreement dated as of 1 October 2015, all but one of the Vendors of Emefcy Ltd (Israel) are entitled to additional shares upon the achievement of defined milestones ("Vendor Shareholders").
The Company announced on 29 March 2016 the achievement of the First Milestone three months ahead of schedule, through the initial shipment of MABR modules to the first commercial municipal wastewater treatment plant at Ha'Yogev in Israel. As a consequence, an additional 22,500,000 shares were issued to the Vendor Shareholders at that time.
Due in large part to the commercialization of the MABR technology having exceeded initial expectations, the Second and final Milestone has now been achieved. Accordingly, a further 22,500,000 Fluence shares are proposed to be issued to the Vendor Shareholders within seven days ("Second Milestone Shares"). The Second Milestone Shares will equate to approximately 5% of Fluence's expanded issued capital of approximately 416 million shares.
The remaining Vendor is True North who, pursuant to the Emefcy Ltd Share Exchange and Purchase Agreement, received cash and a redeemable note instead of Second Milestone Shares on the sale of its interest in Emefcy Ltd. The satisfaction of the Second Milestone results in the remaining USD1 million face value of True North's redeemable note being payable on or about 23 June 2018. This sum has previously been brought to account as a liability in the balance sheet.
The achievement of the Second Milestone is a trigger to bring forward the release of 18,481,080 of the previously issued Fluence shares from voluntary escrow. In addition, a total of 46,549,528 Fluence shares issued to the Vendor Shareholders, including a proportion of the First and Second Milestone Shares, and two other entities will continue to be subject to mandatory and voluntary escrow provisions which will expire on 23 December 2017. Details of the escrow arrangements have been published in earlier releases.
We are pleased to advise that a number of key Vendor Shareholders who hold approximately 99 million Fluence shares in aggregate out of total Vendor Shares of 101.4 million shares, have each informed the Company that they intend to voluntarily continue to hold their Fluence shares, or where sales are necessary will do so either off-market or through a designated broker who typically conducts on-market sales where a buyer is identified prior to executing the trade, and until such time as the Company is advised otherwise.
About Fluence Corporation Ltd
Fluence Corporation (ASX:FLC) (OTCMKTS:EMFGF) is a leader in the decentralized water, wastewater and reuse treatment markets, with its Smart Products Solutions, including Aspiral, NIROBOX, NIROFLEX and SUBRE. Fluence offers an integrated range of services across the complete water cycle, from early stage evaluation, through design and delivery to ongoing support and optimization of water related assets, as well as Build Own Operate Transfer (BOOT) and other recurring revenue solutions. With established operations in North America, South America, the Middle East, Europe and China, Fluence has experience operating in over 70 countries worldwide and enables businesses and communities worldwide to maximize their water resources.
Further information can be found at https://www.fluencecorp.com/
| ||
|
